再评早期非小细胞肺癌之辅助治疗

Re-evaluation of Adjuvant Therapy for Early Stage Non-Small Cell Lung Cancer

下载PDF

导出

作者吴一龙

机构地区广东省人民医院肿瘤中心

出处《循证医学》 CSCD 2006年第4期193-195,共3页 The Journal of Evidence-Based Medicine

关键词肺肿瘤辅助治疗循证医学 lung neoplasms adjuvant therapy evidence-based medicine

参考文献7

1Strauss GM, Hemdon JE, Maddaus MA, et al. Adjuvant chemotherapy in stage Ⅰ B non-small cell lung cancer(NSCLC): Update of Cancer and Leukemia Group B(CALGB)protocol 9633[J]. J Clin Oncol, 2006,24(18S):7007.
2Dowlati A, Gray R, Johnson DH, et al. Prospective correlative assessment of biomarkers in E4599 randomized phase Ⅱ/Ⅲ trial of carboplatin and paclitaxel ± bevacizumab in advanced non-small cell lung cancer(NSCLC) [J]. J Clin Oncol, 2006,24(18S) : 7027.
3Pignon JP, Tribodet H, Scagliotti GV, et al. Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4 584 patients [J]. J Clin Oncol, 2006,24(18S) : 7008.
4Maddaus MA, Wang X, Vollmer RT, et al. CALGB 9761: A prospective analysis of IHC and PCR based detection of occult metastatic disease in stage I NSCLC [J]. J Clin Oncol, 2006,24(18S) : 7030.
5Sofia J, Haddad V, Olaussen KA, et al. Immunohistochemical staining of the Excision Repair Cross-Complementing 1(ERCC1) protein as predictor for benefit of adjuvant chemotherapy (CT) in the International Lung Cancer Trial(IALT) [J]. J Clin Oncol, 2006,24(18S):7010.
6Harpole DH, Petersen R, Mukherjee S, et al. A genomic strategy to refine prognosis in early stage non-small cell lung carcinoma ( NSCLC ) [ J ]. J Clin Oncol, 2006,24 (18S) : 7026.
7Kikuchi T, Massion PP, Shyr Y, et al. Proteomic analysis of lung cancer tumors [ J ]. J Clin Oncol, 2006,24 (18S) : 7028.

循证医学

2006年第4期

内容加载中请稍等...